Magnera Reports Record $99 Million in Operating Cash Flow in Fourth Quarter
Key Facts
Magnera announced its fourth-quarter and fiscal 2026 results on November 18, 2026, saying cash generated from operations in the quarter reached a record $99 million. The results showed quarterly sales rising to $851 million, compared with $839 million in the corresponding period of 2025. Adjusted earnings before interest, taxes, depreciation and amortization were also $97 million, up 8% year over year. These figures came as organic volume declined, indicating that adjusted earnings growth occurred alongside weaker volumes in some markets. The company did not provide a comparison between its cash flow and analyst expectations in its results disclosure.
For the full fiscal year, Magnera reported sales of $3,296 million in 2026, compared with $3,204 million in 2025. Sales rose 3% on a reported basis but fell 4% on a comparable basis, according to company data. Adjusted earnings before interest, taxes, depreciation and amortization were $378 million, compared with $354 million on a comparable basis in the prior year, an increase of 4%. That puts the quarter’s performance within a year in which comparable adjusted earnings improved despite a decline in sales on the same basis. The gap between the reported change and the comparable change reflects the different measurement bases presented by the company in its results.
The quarter also faced operating pressures: the company said organic volume fell 4%. Magnera attributed the decline mainly to weaker demand for healthcare products in the Americas, along with continued broad weakness in the European market. By contrast, the company linked the quarter’s improvement in adjusted earnings to a positive $9 million spread between pricing and costs. Chief Executive Kurt Beegle said execution of the Core project, realization of synergies and a focus on operational excellence helped improve the cost structure. He added that these efforts are taking place as the company faces inflationary pressures and changing demand.
The company reported an operating loss of $90 million in the fourth quarter, after posting operating income of $10 million in the corresponding period of 2025. The quarter’s loss included $106 million in impairment charges for goodwill and other assets, according to the disclosure. The results therefore presented a contrast between growth in adjusted earnings and higher operating cash flow on one hand, and the reported operating loss on the other. For fiscal 2026 as a whole, cash flow from operating activities was $178 million. After net additions to property, plant and equipment of $63 million, free cash flow was $115 million.
Magnera said it repaid $57 million of debt during the quarter, bringing total repayments in fiscal 2026 to $122 million. The company said it was committed to strengthening its credit metrics by continuing to repay debt in the near term. This direction is tied to the cash generation shown in the year’s results, with free cash flow reaching $115 million. The company thus identified debt reduction as a stated priority alongside improving its cost structure. The disclosure did not specify an additional repayment timetable beyond describing it as near term.
For fiscal 2027, Magnera expects adjusted earnings before interest, taxes, depreciation and amortization of between $390 million and $410 million. It also set a free cash flow range of $110 million to $130 million, and cash flow from operations of between $195 million and $215 million. These ranges represent the company’s outlook for the coming period, while debt repayment and stronger credit metrics remain among its stated priorities. The company scheduled a call to discuss the results for November 19, 2026, at 10:00 a.m. Eastern Time. The call is expected to provide an opportunity to review the results and the outlook for the coming fiscal year.